Related Experiment Video
Updated: Jan 4, 2026

Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
Optimized Production of Lentiviral Vectors for CAR-T Cell
Pablo Diego Moço1, Mário Soares de Abreu Neto1, Daianne Maciely Carvalho Fantacini1
1Center for Cell-Based Therapy CTC, Regional Blood Center of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
Abstract:
Advances in the use of lentiviral vectors for gene therapy applications have created a need for large-scale manufacture of clinical-grade viral vectors for transfer of genetic materials. Lentiviral vectors can transduce a wide range of cell types and integrate into the host genome of dividing and nondividing cells, resulting in long-term expression of the transgene both in vitro and in vivo. In this chapter, we present a method to transfect human cells, creating an easy platform to produce lentiviral vectors for CAR-T cell application.

